Israel Englander Cure Vac N.V. Call Options Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
Call Options
2 transactions
Others Institutions Holding CVAC
# of Institutions
96Shares Held
12.3MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$12.3 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.8 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.58 Million10.6% of portfolio
-
Ubs Group Ag843KShares$4.61 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL280KShares$1.53 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.03B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...